250
Views
49
CrossRef citations to date
0
Altmetric
Original Articles

Neuropeptide S receptor gene (NPSR) and life events: G × E effects on anxiety sensitivity and its subdimensions

, , , , , , & show all
Pages 17-25 | Received 26 Sep 2011, Accepted 15 Nov 2011, Published online: 09 Mar 2012

References

  • Alpers GW, Pauli P. 2001. Angstsensitivitäts-Index. Würzburg: Julius-Maximilians-Universität.
  • Amstadter AB, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, Gelernter J. 2010. NPY moderates the relation between hurricane exposure and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety 27:270–275.
  • Bandelow B, Alvarez TG, Spath C, Broocks A, Hajak G, Bleich S, Ruther E. 2001. Separation anxiety and actual separation experiences during childhood in patients with panic disorder. Can J Psychiatry 46:948–952.
  • Bandelow B, Spath C, Tichauer GA, Broocks A, Hajak G, Ruther E. 2002. Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder. Compr Psychiatry 43:269–278.
  • Bernier V, Stocco R, Bogusky MJ, Joyce JG, Parachoniak C, Grenier K, et al. 2006. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I. J Biol Chem 281: 24704–24712.
  • Bernstein DP, Fink L. 1998. Childhood trauma questionnaire: A retrospective self-report manual. San Antonio, TX: The Psychological Corporation.
  • Blais MA, Otto MW, Zucker BG, McNally RJ, Schmidt NB, Fava M, Pollack MH. 2001. The anxiety sensitivity index: item analysis and suggestions for refinement. J Pers Assess 77: 272–294.
  • Blechert J, Michael T, Grossman P, Lajtman M, Wilhelm FH. 2007. Autonomic and respiratory characteristics of posttraumatic stress disorder and panic disorder. Psychosom Med 69:935–943.
  • Bouton ME, Mineka S, Barlow DH. 2001. A modern learning theory perspective on the etiology of panic disorder. Psychol Rev 108:4–32.
  • Brown GW, Harris TO. 1993. Aetiology of anxiety and depressive disorders in an inner-city population. 1. Early adversity. Psychol Med 23:143–154.
  • Brugha T, Bebbington P, Tennant C, Hurry J. 1985. The List of Threatening Experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med 15:189–194.
  • Clark DM. 1986. A cognitive approach to panic. Behav Res Ther 24:461–470.
  • Clark SD, Duangdao DM, Schulz S, Zhang L, Liu X, Xu YL, Reinscheid RK. 2011. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry. J Comp Neurol 519:1867–1893.
  • Compas BE, Malcarne VL, Fondacaro KM. 1988. Coping with stressful events in older children and young adolescents. J Consult Clin Psychol 56:405–411.
  • Crowe RR, Goedken R, Samuelson S, Wilson R, Nelson J, Noyes R Jr. 2001. Genomewide survey of panic disorder. Am J Med Genet 105:105–109.
  • Cushing BS, Kramer KM. 2005. Mechanisms underlying epigenetic effects of early social experience: the role of neuropeptides and steroids. Neurosci Biobehav Rev 29:1089–1105.
  • Dannlowski U, Kugel H, Franke F, Stuhrmann A, Hohoff C, Zwanzger P, et al. 2011. Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacology 36:1879–1885.
  • Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, et al. 2011. Neuropeptide S receptor gene – converging evidence for a role in panic disorder. Mol Psychiatry 16:938–948.
  • Donner J, Haapakoski R, Ezer S, Melen E, Pirkola S, Gratacos M, et al. 2010. Assessment of the neuropeptide S system in anxiety disorders. Biol Psychiatry 68:474–483.
  • Duangdao DM, Clark SD, Okamura N, Reinscheid RK. 2009. Behavioral phenotyping of neuropeptide S receptor knockout mice. Behav Brain Res 205:1–9.
  • Ebner K, Rjabokon A, Pape HC, Singewald N.2011. Increased in vivo release of neuropeptide S in the amygdala of freely moving rats after local depolarisation and emotional stress. Amino Acids 41:991–996.
  • Faravelli C. 1985. Life events preceding the onset of panic disorder. J Affect Disord 9:103–105.
  • Gast U, Rodewald F, Benecke HH, Driessen M. Deutsche Bearbeitung des Childhood Traum Questionnaire (unautorisiert). Hannover: Medizinische Hochschule; 2001.
  • Grabe HJ, Spitzer C, Schwahn C, Marcinek A, Frahnow A, Barnow S, et al. 2009. Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population. Am J Psychiatry 166:926–933.
  • Härter MC, Conway KP, Merikangas KR. 2003. Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci 253:313–320.
  • Henry B, Moffitt TE, Caspi A, Langley J, Silva PA. 1994. On the “Remembrance of Things Past” A longitudinal evaluation of the retrospective method. Psychol Assess 6:92–101.
  • Jackson Y, Warren JS. 2000. Appraisal, social support, and life events: predicting outcome behavior in school-age children. Child Dev 71:1441–1457.
  • Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1992. Childhood parental loss and adult psychopathology in women. A twin study perspective. Arch Gen Psychiatry 49:109–116.
  • Klauke B, Deckert J, Reif A, Pauli P, Domschke K. 2010. Life events in panic disorder – an update on “candidate stressors”. Depress Anxiety 27:716–730.
  • Klauke B, Deckert J, Reif A, Pauli P, Zwanzger P, Baumann C, et al. 2011. Serotonin transporter gene and childhood trauma – a G x E effect on anxiety sensitivity. Depress Anxiety 28: 1048–1057.
  • Knowles JA, Fyer AJ, Vieland VJ, Weissman MM, Hodge SE, Heiman GA, et al. 1998. Results of a genome-wide genetic screen for panic disorder. Am J Med Genet 81:139–147.
  • Kraemer HC, Blasey CM. 2004. Centring in regression analyses: a strategy to prevent errors in statistical inference. Int J Methods Psychiatr Res 13(3):141–51.
  • Laucht M, Treutlein J, Blomeyer D, Buchmann AF, Schmid B, Becker K, et al. 2009. Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults. Int J Neuropsychopharmacol 12:737–747.
  • Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan K, et al. 1997. The Mini International Neuropsychiatric Interview (M.I.N.I.), a short diagnostic interview: Reliability and validity according to the CIDI. Eur Psychiatry 12:224–231.
  • Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, Logue SF, Neal SJ, et al. 2008. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology (Berlin) 197:601–611.
  • Logue MW, Vieland VJ, Goedken RJ, Crowe RR. 2003. Bayesian analysis of a previously published genome screen for panic disorder reveals new and compelling evidence for linkage to chromosome 7. Am J Med Genet B Neuropsychiatr Genet 121B:95–99.
  • Muthén LK, Muthén BO. 2007. Mplus user´s guide. 5th ed. Los Angeles, CA: Muthén & Muthén.
  • Nugent NR, Tyrka AR, Carpenter LL, Price LH. 2011. Gene- environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berlin) 214: 175–196.
  • Okamura N, Reinscheid RK. 2007. Neuropeptide S: a novel modulator of stress and arousal. Stress 10:221–226.
  • Okamura N, Hashimoto K, Iyo M, Shimizu E, Dempfle A, Friedel S, Reinscheid RK. 2007. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention–deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:1444–1448.
  • Okamura N, Garau C, Duangdao DM, Clark SD, Jungling K, Pape HC, Reinscheid RK. 2011. Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain. Neuropsychopharmacology 36:744–752.
  • Pape HC, Jungling K, Seidenbecher T, Lesting J, Reinscheid RK. 2010. Neuropeptide S: a transmitter system in the brain regulating fear and anxiety. Neuropharmacology 58:29–34.
  • Poikolainen K, Kanerva R, Lonnqvist J. 1995. Life events and other risk factors for somatic symptoms in adolescence. Pediatrics 96:59–63.
  • Pynoos RS, Steinberg AM, Piacentini JC. 1999. A developmental psychopathology model of childhood traumatic stress and intersection with anxiety disorders. Biol Psychiatry 46: 1542–1554.
  • Raczka KA, Gartmann N, Mechias ML, Reif A, Buchel C, Deckert J, Kalisch R. 2010. A neuropeptide S receptor variant associated with overinterpretation of fear reactions: a potential neurogenetic basis for catastrophizing. Mol Psychiatry 15:1045, 1067–45, 1074.
  • Reinscheid RK, Xu YL. 2005. Neuropeptide S as a novel arousal promoting peptide transmitter. FEBS J 272:5689–5693.
  • Reinscheid RK, Xu YL, Okamura N, Zeng J, Chung S, Pai R, Wang Z, Civelli O. 2005. Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther 315:1338–1345.
  • Reiss S, Peterson RA, Gursky DM, McNally RJ. 1986. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24:1–8.
  • Rizzi A, Vergura R, Marzola G, Ruzza C, Guerrini R, Salvadori S, Regoli D, Calo G. 2008. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol 154:471–479.
  • Scher CD, Stein MB. 2003. Developmental antecedents of anxiety sensitivity. J Anx Disord 17:253–269.
  • Schmidt NB, Lerew DR, Jackson RJ. 1997. The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. J Abnorm Psychol 106:355–364.
  • Schmidt NB, Lerew DR, Jackson RJ. 1999. Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: replication and extension. J Abnorm Psychol 108:532–537.
  • Schmidt NB, Zvolensky MJ, Maner JK. 2006. Anxiety sensitivity: prospective prediction of panic attacks and Axis I pathology. J Psychiatr Res 40:691–699.
  • Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV, et al. 2006. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 147:3510–3518.
  • Stein MB, Walker JR, Anderson G, Hazen AL, Ross CA, Eldridge G, Forde DR. 1996. Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample. Am J Psychiatry 153:275–277.
  • Stein MB, Schork NJ, Gelernter J. 2008. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology 33:312–319.
  • Telch MJ, Shermis MD, Lucas JA. 1989. Anxiety sensitivity: Unitary personality trait or domain-specific appraisals?. J Anx Disord 3:25–32.
  • Watt MC, Stewart SH. 2003. The role of anxiety sensitivity components in mediating the relationship between childhood exposure to parental dyscontrol and adult anxiety symptoms. J Psychopathol Behav Assess 25:167–176.
  • Wegener G, Finger BC, Elfving B, Keller K, Liebenberg N, Fischer CW, et al. 2011. Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression. Int J Neuropsychopharmacol 1–13.
  • Wingenfeld K, Spitzer C, Mensebach C, Grabe HJ, Hill A, Gast U, et al. 2010. The German version of the Childhood Trauma Questionnaire (CTQ): preliminary psychometric properties. Psychother Psychosom Med Psychol 60:442–450.
  • Witt SH, Buchmann AF, Blomeyer D, Nieratschker V, Treutlein J, Esser G, et al. 2011. An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology 36:1010–1020.
  • Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, et al. 2004. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43:487–497.
  • Xu YL, Gall CM, Jackson VR, Civelli O, Reinscheid RK. 2007. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500:84–102.
  • Zhu H, Mingler MK, McBride ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, et al. 2010. Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Psychoneuroendocrinology 35:1119–1132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.